Abiopharma

🔍 Grafton Jennifer S (Executive)

Company: Rare Earths Americas, Inc. (REA)

Report Date: 2026-08-12

Detailed Transactions and Holdings:

• Acquired 40,000 shares of Performance Based Restricted Stock Units (Derivative)
  Date: 2026-08-12 | Code: A | equity_swap_involved: false | shares_owned_after: 40,000.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1

Footnotes:

• F1: Each performance-based restricted stock unit ("PSU") represents a contingent right to receive one share of Common Stock. The PSUs will vest 25% if the volume weighted average price ("VWAP") during any period of 20 consecutive trading days during a three year period commencing August 12, 2026 (the "Performance Period") equals or exceeds $22.50, 25% if the VWAP during any period of 20 consecutive trading days during the Performance Period equals or exceeds $25.00, 25% if the VWAP during any period of 20 consecutive trading days during the Performance Period equals or exceeds $27.50 and 25% of the PSUs will vest if the VWAP during any period of 20 consecutive trading days during the Performance Period equals or exceeds $30.00, subject to continuous service with Rare Earths Americas, Inc. through each such date. Following vesting, the Reporting Person shall be subject to an 18-month holding period.